• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BALT USA OPTIMA COIL SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BALT USA OPTIMA COIL SYSTEM Back to Search Results
Model Number OPTI0830CSFMX
Device Problems Stretched (1601); Premature Separation (4045)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/20/2024
Event Type  malfunction  
Event Description
It was reported that: " sex: unknown disease name: 10mm an in ic-top procedure: emergency procedure micro catheter: sl-10/stryker assist stent: unknown y connector: unknown used coils: optimax, 2 targetxcel/stryker after placing 1 optimax coil and 2 targetxcel coils, the physician inserted optimax 8×30(reported coil).The physician performed several attempts of repositioning.After repeated attempts, the physician found that, despite he operated delivery wire the implant coil(the tip of it was placed in the target lesion) did no move no longer.It turned out that the implant coil got unraveled and retrieving attempt with snare were difficult.Eventually, the implant coil was torn off and partially remained in the aneurysm and some part of filament remained in the mother vessel.After that the procedure was continued with competitive coils and the loop of coil has been pushed out of the aneurysm.Thus the physician completed procedure by jacking up the stent and holding down part of the optimax strand with the stent, although it was a sah.It is unknown whether the physician performed before use check or not." incident report form submitted for this complaint indicates that no patient injury was sustained.
 
Manufacturer Narrative
Balt usa reference (b)(4).Investigaiton pending the return of the complaint device for analysis.The submission of this report or related information to the fda, and its release by fda, does not reflect a conclusion by the party submitting this report of the fda that the report or related information is an admission that the manufacturer, their employees, or the device caused or contributed to the reportable event.
 
Event Description
It was reported that: " sex: unknown.Disease name: 10mm an in ic-top.Procedure: emergency procedure.Micro catheter: sl-10/stryker.Assist stent: unknown.Y connector: unknown.Used coils: optimax, 2 targetxcel/stryker. after placing 1 optimax coil and 2 targetxcel coils, the physician inserted optimax 8×30(reported coil).The physician performed several attempts of repositioning.After repeated attempts, the physician found that, despite he operated delivery wire the implant coil(the tip of it was placed in the target lesion) did no move no longer.It turned out that the implant coil got unraveled and retrieving attempt with snare were difficult.Eventually, the implant coil was torn off and partially remained in the aneurysm and some part of filament remained in the mother vessel.After that the procedure was continued with competitive coils and the loop of coil has been pushed out of the aneurysm.Thus the physician completed procedure by jacking up the stent and holding down part of the optimax strand with the stent, although it was a sah.It is unknown whether the physician performed before use check or not." incident report form submitted for this complaint indicates that no patient injury was sustained.
 
Manufacturer Narrative
Balt usa reference #(b)(4).The returned device was inspected in our quality laboratory.During our analysis: - we observed only the implant coil was returned; - we observed severe stretching along the implant, approximately 9cm proximal from the distal end; - we observed the sr thread within the implant coil to be opaque in color; - we observed the distal tip of the implant coil to be broken.Root cause of the reported issue endured by the coil system cannot definitively be determined due to the incomplete device return, however it is evident that the implant coil had become stretched and further prematurely detached from the delivery pusher.Upon device return, we observed severe stretching along the implant and the sr thread within the implant coil to be opaque in color, confirming that the implant coil had become stretched.The user reported that after multiple attempts to try to reposition the implant coil, it was discovered that the implant coil would no longer move when the delivery pusher was manipulated.During the procedure, a snare device was required to attempt to retrieve the device, however attempts served unsuccessful and resulted in the implant coil becoming broken.The procedure was concluded with an additional stent placed in order to secure the broken portion of the implant coil.The exact cause of the premature detachment cannot be determined without the delivery pusher and associated microcatheter used during the incident.If the implant coil were to have become damaged, this can lead to excessive friction being applied to the implant coil while it is moving through the microcatheter, which can cause the implant coil to prematurely detach.Moreover, if the microcatheter used during the incident had become damaged, this could have led to the reported issue by causing friction when advancing and retracting the coil system.A review of the lhr indicated that the unit was free from visual damage, including the implant coil at the point of the 100% final inspection.Review of the lot history records did not reveal any in-process or lot-specific issue that could account for the observation.No additional complaints against lot number f231100305 has been made for the same issue.Comprehensive analysis of this failure mode has remained subject to monitoring for any unacceptable increase in trend.The submission of this report or related information to the fda, and its release by fda, does not reflect a conclusion by the party submitting this report of the fda that the report or related information is an admission that the manufacturer, their employees, or the device caused or contributed to the reportable event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIMA COIL SYSTEM
Type of Device
OPTIMA
Manufacturer (Section D)
BALT USA
29 parker
irvine CA 92618
Manufacturer Contact
david vu
29 parker
irvine, CA 92618
9497881443
MDR Report Key18741638
MDR Text Key335813206
Report Number3014162263-2024-00005
Device Sequence Number1
Product Code HCG
UDI-Device Identifier00818053025259
UDI-Public(01)00818053025259(11)231108(17)281108(10)F231100305
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K200030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberOPTI0830CSFMX
Device Lot NumberF231100305
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/21/2024
Initial Date FDA Received02/20/2024
Supplement Dates Manufacturer Received01/21/2024
Supplement Dates FDA Received03/12/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/08/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-